About this Journal Submit a Manuscript Table of Contents
Pathology Research International
Volume 2011 (2011), Article ID 897292, 7 pages
http://dx.doi.org/10.4061/2011/897292
Review Article

Advances in Fine Needle Aspiration Cytology for the Diagnosis of Pulmonary Carcinoma

Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA

Received 5 February 2011; Accepted 3 May 2011

Academic Editor: Darshana Jhala

Copyright © 2011 Adnan Hasanovic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. M. Wahidi, J. A. Govert, R. K. Goudar, M. K. Gould, and D. C. McCrory, “Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition),” Chest, vol. 132, no. 3, pp. 94S–107S, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. D. R. Aberle, C. D. Berg, W. C. Black, et al., “The national lung screening trial: overview and study design,” Radiology, vol. 258, no. 1, pp. 243–253, 2011.
  3. A. Sandler, “Bevacizumab in non-small cell lung cancer,” Clinical Cancer Research, vol. 13, no. 15, part 2, pp. s4613–s4616, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. G. Scagliotti, N. Hanna, F. Fossella et al., “The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies,” Oncologist, vol. 14, no. 3, pp. 253–263, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. L. Marks, S. Broderick, Q. Zhou et al., “Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma,” Journal of Thoracic Oncology, vol. 3, no. 2, pp. 111–116, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. E. L. Kwak, Y. J. Bang, D. R. Camidge et al., “Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer,” The New England Journal of Medicine, vol. 363, no. 18, pp. 1693–1703, 2010. View at Publisher · View at Google Scholar · View at PubMed
  7. R. Nizzoli, M. Tiseo, F. Gelsomino et al., “Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer,” Journal of Thoracic Oncology, vol. 6, no. 3, pp. 489–493, 2011. View at Publisher · View at Google Scholar · View at PubMed
  8. M. F. Zakowski, “Fine-needle aspiration cytology of tumors: diagnostic accuracy and potential pitfalls,” Cancer Investigation, vol. 12, no. 5, pp. 505–515, 1994. View at Scopus
  9. C. J. R. Stewart and I. S. Stewart, “Immediate assessment of fine needle aspiration cytology of lung,” Journal of Clinical Pathology, vol. 49, no. 10, pp. 839–843, 1996. View at Scopus
  10. C. P. Mullan, B. E. Kelly, P. K. Ellis, S. Hughes, N. Anderson, and W. G. McCluggage, “CT-guided fine-needle aspiration of lung nodules: effect on outcome of using coaxial technique and immediate cytological evaluation,” Ulster Medical Journal, vol. 73, no. 1, pp. 32–36, 2004. View at Scopus
  11. J. H. M. Austin and M. B. Cohen, “Value of having a cytopathologist present during percutaneous fine-needle aspiration biopsy of lung: report of 55 cancer patients and metaanalysis of the literature,” American Journal of Roentgenology, vol. 160, no. 1, pp. 175–177, 1993. View at Scopus
  12. W. D. Travis, B. Corrin, Y. Shimosato, and E. Brambilla, World Health Organization International Histological Classification of Tumours. Histological Typing of Lung and Pleural Tumours, Springer, 3rd edition, 1999.
  13. W. D. Travis, H. K. Muller-Hermelink, and C. C. Harris, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, International Agency For Research On Cancer, Lyon, France, 2004.
  14. W. D. Travis, E. Brambilla, M. Noguchi et al., “International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma,” Journal of Thoracic Oncology, vol. 6, no. 2, pp. 244–285, 2011. View at Publisher · View at Google Scholar · View at PubMed
  15. M. F. Zakowski, “Pathology of small cell carcinoma of the lung,” Seminars in Oncology, vol. 30, no. 1, pp. 3–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. P. I. Delgado, M. Jorda, and P. Ganjei-Azar, “Small cell carcinoma versus other lung malignancies: diagnosis by fine-needle aspiration cytology,” Cancer, vol. 90, no. 5, pp. 279–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. C. S. Sigel, A. L. Moreira, W. D. Travis et al., “Subtyping of Non-Small Cell Lung Carcinoma (NSCLC): A Comparison of Small Biopsy and Cytology Specimens,” Journal of Thoracic Oncology, (In press).
  18. N. Rekhtman, S. M. Brandt, C. S. Sigel et al., “Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing,” Journal of Thoracic Oncology, vol. 6, no. 3, pp. 451–458, 2011. View at Publisher · View at Google Scholar · View at PubMed
  19. J. Shimizu, M. Oda, Y. Hayashi, A. Nonomura, and Y. Watanabe, “A clinicopathologic study of resected cases of adenosquamous carcinoma of the lung,” Chest, vol. 109, no. 4, pp. 989–994, 1996. View at Scopus
  20. M. Wu, A. H. Szporn, D. Zhang et al., “Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers,” Diagnostic Cytopathology, vol. 33, no. 4, pp. 223–227, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. A. G. Nicholson, D. Gonzalez, P. Shah et al., “Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis,” Journal of Thoracic Oncology, vol. 5, no. 4, pp. 436–441, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. G. Rossi, M. Papotti, M. Barbareschi, P. Graziano, and G. Pelosi, “Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 27, no. 28, pp. e141–e142, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. A. Dejmek, P. Naucler, A. Smedjeback et al., “Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions,” Diagnostic Cytopathology, vol. 35, no. 8, pp. 493–497, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. L. M. Stoll, M. W. Johnson, E. Gabrielson, F. Askin, D. P. Clark, and Q. K. Li, “The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas,” Cancer Cytopathology, vol. 118, no. 6, pp. 441–449, 2010.
  25. J. Fukuoka, T. Dracheva, J. H. Shih et al., “Desmoglein 3 as a prognostic factor in lung cancer,” Human Pathology, vol. 38, no. 2, pp. 276–283, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. V. Monica, P. Ceppi, L. Righi et al., “Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung,” Modern Pathology, vol. 22, no. 5, pp. 709–717, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. Lebanony, H. Benjamin, S. Gilad et al., “Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma,” Journal of Clinical Oncology, vol. 27, no. 12, pp. 2030–2037, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. J. A. Bishop, H. Benjamin, H. Cholakh, A. Chajut, D. P. Clark, and W. H. Westra, “Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach,” Clinical Cancer Research, vol. 16, no. 2, pp. 610–619, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. V. D. Vescovo, C. Cantaloni, A. Cucino et al., “MiR-205 expression levels in nonsmall cell lung cancerdo not always distinguish adenocarcinomas from squamous cell carcinomas,” American Journal of Surgical Pathology, vol. 35, no. 2, pp. 268–275, 2011. View at Publisher · View at Google Scholar · View at PubMed
  30. H. Cheng, X. Xu, D. B. Costa, C. A. Powell, and B. Halmos, “Molecular testing in lung cancer: the time is now,” Current Oncology Reports, vol. 12, no. 5, pp. 335–348, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. D. P. Clark, “Seize the opportunity: underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions,” Cancer Cytopathology, vol. 117, no. 5, pp. 289–297, 2009. View at Scopus
  32. S. Sanati, D. W. Lu, E. Schmidt, A. Perry, L. P. Dehner, and J. D. Pfeifer, “Cytologic diagnosis of ewing sarcoma/peripheral neuroectodermal tumor with paired prospective molecular genetic analysis,” Cancer, vol. 111, no. 3, pp. 192–199, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. N. K. B. Pang, S. Y. Chin, M. E. Nga et al., “Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours,” Cytopathology, vol. 20, no. 5, pp. 297–303, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. O. C. J. Schuurbiers, M. G. Looijen-Salamon, M. J. L. Ligtenberg, and H. F. M. Van Der Heijden, “A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates,” Journal of Thoracic Oncology, vol. 5, no. 10, pp. 1664–1667, 2010. View at Publisher · View at Google Scholar · View at PubMed
  35. J. H. Smouse, E. S. Cibas, P. A. Jänne, V. A. Joshi, K. H. Zou, and N. I. Lindeman, “EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer,” Cancer Cytopathology, vol. 117, no. 1, pp. 67–72, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. M. E. Arcila, G. R. Oxnard, K. Nafa et al., “Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay,” Clinical Cancer Research, vol. 17, no. 5, pp. 1169–1180, 2011. View at Publisher · View at Google Scholar · View at PubMed
  37. C. R. Kelsey, L. B. Marks, D. Hollis et al., “Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients,” Cancer, vol. 115, no. 22, pp. 5218–5227, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. G. Sica, A. Yoshizawa, C. S. Sima et al., “A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors,” The American Journal of Surgical Pathology, vol. 34, no. 8, pp. 1155–1162, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. D. E. Rudomina, O. Lin, and A. L. Moreira, “Cytologic diagnosis of pulmonary adenocarcinoma with micropapillary pattern: does it correlate with the histologic findings?” Diagnostic Cytopathology, vol. 37, no. 5, pp. 333–339, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. C. S. Sigel, D. E. Rudomina, N. Rekhtman, W. D. Travis, K. Geisinger, and A. L. Moreira, “Predicting Pulmonary Adenocarcinoma Outcome Based on a Cytology Grading System,” Cancer Cytopathol, (In press).
  41. M. Brevet, M. Arcila, and M. Ladanyi, “Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR,” Journal of Molecular Diagnostics, vol. 12, no. 2, pp. 169–176, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. J. H. Paik, G. Choe, H. Kim et al., “Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization,” Journal of Thoracic Oncology, vol. 6, no. 3, pp. 466–472, 2011. View at Publisher · View at Google Scholar · View at PubMed
  43. E. S. Yi, J. M. Boland, J. J. Maleszewski et al., “Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH,” Journal of Thoracic Oncology, vol. 6, no. 3, pp. 459–465, 2011. View at Publisher · View at Google Scholar · View at PubMed
  44. J. Eckardt, K. E. Olsen, and P. B. Licht, “Endobronchial ultrasound-guided transbronchial needle aspiration of undiagnosed chest tumors,” World Journal of Surgery, vol. 34, no. 8, pp. 1823–1827, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. M. A. Friedlander, C. S. Sigel, D. Finley, et al., “Endobronchial ultrasound-guided transbronchial needle aspiration cytology—the memorial sloan-kettering cancer center experience,” Cancer Cytopathology, vol. 118, no. 5, pp. 363–364, 2010.
  46. K. G. Tournoy, F. De Ryck, L. R. Vanwalleghem et al., “Endoscopic ultrasound reduces surgical mediastinal staging in lung cancer: a randomized trial,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 5, pp. 531–535, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. T. S. Weiser, K. Hyman, J. Yun, V. Litle, C. Chin, and S. J. Swanson, “Electromagnetic navigational bronchoscopy: a surgeon's perspective,” Annals of Thoracic Surgery, vol. 85, no. 2, pp. S797–S801, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. B. Lamprecht, P. Porsch, C. Pirich, and M. Studnicka, “Electromagnetic navigation bronchoscopy in combination with PET-CT and rapid on-site cytopathologic examination for diagnosis of peripheral lung lesions,” Lung, vol. 187, no. 1, pp. 55–59, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. G. Schreiber and D. C. McCrory, “Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence,” Chest, vol. 123, no. 1, pp. 115S–128S, 2003. View at Scopus
  50. L. Santambrogio, M. Nosotti, N. Bellaviti, G. Pavoni, F. Radice, and V. Caputo, “CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation,” Chest, vol. 112, no. 2, pp. 423–425, 1997. View at Scopus